Eva Romanovsky

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Genome Wide Association

Autism Spectrum Disorder

Lymph Node Metastasis

Transcription Factor

Top Venues

British journal of cancer

Cell death discovery

Molecular psychiatry

This page only lists publications with an associated author ORCID identifier.

Publications

Jan Budczies, Eva Romanovsky, Martina Kirchner, Olaf Neumann, Miriam Blasi, Johannes Schnorbach, Rajiv Shah, Farastuk Bozorgmehr, Rajkumar Savai, Thorsten Stiewe, Solange Peters, Peter Schirmacher, Michael Thomas, Daniel N Kazdal, Petros Christopoulos, Albrecht Stenzinger
KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma. British journal of cancer 131 (3) (2024)
Eva Romanovsky, Ashwani Choudhary, David Peles, Ahmad M Abu-Akel, Shani Stern
Uncovering convergence and divergence between autism and schizophrenia using genomic tools and patients' neurons. Molecular psychiatry (2024)
Jan Budczies, Eva Romanovsky, Martina Kirchner, Olaf Neumann, Miriam Blasi, Johannes Schnorbach, Rajiv Shah, Farastuk Bozorgmehr, Rajkumar Savai, Thorsten Stiewe, Solange Peters, Peter Schirmacher, Michael Thomas, Daniel N Kazdal, Petros Christopoulos, Albrecht Stenzinger
KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma. British journal of cancer (2024)
Jan Budczies, Eva Romanovsky, Martina Kirchner, Olaf Neumann, Miriam Blasi, Johannes Schnorbach, Rajiv Shah, Farastuk Bozorgmehr, Rajkumar Savai, Thorsten Stiewe, Solange Peters, Peter Schirmacher, Michael Thomas, Daniel N Kazdal, Petros Christopoulos, Albrecht Stenzinger
KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma. British journal of cancer 131 (3) (2024)
Jan Budczies, Eva Romanovsky, Martina Kirchner, Olaf Neumann, Miriam Blasi, Johannes Schnorbach, Rajiv Shah, Farastuk Bozorgmehr, Rajkumar Savai, Thorsten Stiewe, Solange Peters, Peter Schirmacher, Michael Thomas, Daniel N Kazdal, Petros Christopoulos, Albrecht Stenzinger
KRAS and TP53 co-mutation predicts benefit of immune checkpoint blockade in lung adenocarcinoma. British journal of cancer 131 (3) (2024)
Eva Romanovsky, Klaus Kluck, Iordanis Ourailidis, Michael Menzel, Susanne Beck, Markus Ball, Daniel Kazdal, Petros Christopoulos, Peter Schirmacher, Thorsten Stiewe, Albrecht Stenzinger, Jan Budczies
Homogenous TP53mut-associated tumor biology across mutation and cancer types revealed by transcriptome analysis. Cell death discovery 9 (1) (2023)